Your browser doesn't support javascript.
loading
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Duell, Johannes; Abrisqueta, Pau; Andre, Marc; Gaidano, Gianluca; Gonzales-Barca, Eva; Jurczak, Wojciech; Kalakonda, Nagesh; Liberati, Anna Marina; Maddocks, Kami J; Menne, Tobias; Nagy, Zsolt; Tournilhac, Olivier; Kuffer, Christian; Bakuli, Abhishek; Amin, Aasim; Gurbanov, Konstantin; Salles, Gilles.
Afiliação
  • Duell J; Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg. Duell_J@ukw.de.
  • Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona.
  • Andre M; Centre Hospitalier Universitaire CHU UCL Namur, Belgium.
  • Gaidano G; Division of Hematology, Department of Translational Medicine University of Eastern Piedmont and Ospedale Maggiore della Carità, Novara.
  • Gonzales-Barca E; Department of Hematology, Institut Català d'Oncologia, Hospitalet de Llobregat, IDIBELL, Univeristat de Barcelona, Barcelona.
  • Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków.
  • Kalakonda N; Department of Molecular and Clinical Cancer University of Liverpool, Liverpool, United Kingdom.
  • Liberati AM; Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni.
  • Maddocks KJ; Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH.
  • Menne T; Freeman Hospital, The Newcastle upon Tyne Hospitals, Newcastle upon Tyne, United Kingdom.
  • Nagy Z; Semmelweis University, Budapest, Hungary.
  • Tournilhac O; CHU de Clermont-Ferrand, Lyon.
  • Kuffer C; MorphoSys AG, Planegg.
  • Bakuli A; MorphoSys AG, Planegg.
  • Amin A; MorphoSys AG, Planegg.
  • Gurbanov K; MorphoSys AG, Planegg.
  • Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Haematologica ; 109(2): 553-566, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37646664

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article País de publicação: Itália